US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 565.680
  • -45.180-7.40%
Trading Apr 29 15:03 ET
61.07BMarket Cap14.38P/E (TTM)

About Regeneron Pharmaceuticals Company

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Company Profile

SymbolREGN
Company NameRegeneron Pharmaceuticals
Listing DateApr 2, 1991
Issue Price22.00
Founded1988
CEODr. Leonard S. Schleifer,M.D.,PhD
MarketNASDAQ
Employees15106
Fiscal Year Ends12-31
Address777 Old Saw Mill River Road
CityTarrytown
ProvinceNew York
CountryUnited States of America
Zip Code10591-6707
Phone1-914-847-7000

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Leonard S. Schleifer,M.D.,PhD
  • Co-Chairman of the Board, Co-President and Chief Executive Officer
  • 8.18M
  • Christopher R. Fenimore
  • Executive Vice President, Finance and Chief Financial Officer
  • --
  • Dr. George D. Yancopoulos,M.D.,PhD
  • Co-Chairman of the Board, Co-President and Chief Scientific Officer
  • 7.76M
  • Daniel P. Van Plew
  • Executive Vice President and General Manager, Industrial Operations and Product Supply
  • 8.76M
  • Jason Pitofsky
  • Principal Accounting Officer, Vice President and Controller
  • --
  • Marion McCourt
  • Executive Vice President, Commercial
  • --
  • Joseph J. Larosa
  • Executive Vice President, General Counsel and Secretary
  • --
  • Andrew J Murphy
  • Executive Vice President, Research
  • 8.43M
  • Dr. Neil Stahl,PhD
  • Executive Vice President, Research and Development
  • --
  • Kathryn Guarini, PhD
  • Director
  • 1.03M
  • Dr. David P. Schenkein, M.D.
  • Director
  • 1.03M
  • Dr. N. Anthony Coles, M.D.
  • Independent Director
  • 704.99K
  • Christine A. Poon
  • Lead Independent Director
  • 748.01K
  • George L. Sing
  • Independent Director
  • 724.99K
  • Arthur Frederick Ryan
  • Independent Director
  • 724.99K
  • Dr. Michael S. Brown, M.D.
  • Independent Director
  • 728.99K
  • Dr. Joseph L. Goldstein,M.D.
  • Independent Director
  • 709.99K
  • Dr. Huda Y. Zoghbi, M.D.
  • Independent Director
  • 714.99K
  • Dr. Craig B. Thompson,M.D.
  • Independent Director
  • 247.79K
  • Dr. Bonnie L. Bassler, PhD
  • Independent Director
  • 709.99K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.